Soheil Meshinchi

21.8k citations
328 papers · 8.9k indexed · 2 hit papers · h-index 49

Soheil Meshinchi

308 papers receiving 8.7k citations

Hit Papers

Biology, Risk Stratification, and Therapy of Pediatric Ac...201120262016202120112014100200300400500

Peers

Soheil Meshinchi
Comparison fields: 5 of 119
  • Hematology 5.8k
  • Molecular Biology 4.2k
  • Public Health, Environmental and Occupational Health 2.7k
  • Oncology 1.4k
  • Genetics 1.2k
Replace Paresh Vyas with:
Paresh Vyas United Kingdom
Mark J. Levis United States
Valeria Santini Italy
Richard B. Lock Australia
Beverly S. Mitchell United States
Patrick Mayeux France
Carolyn A. Felix United States
Fortunato Morabito Italy
Kimberly Stegmaier United States
Daniela S. Krause United States
Soheil Meshinchi relative to Paresh Vyas United Kingdom Paresh Vyas's profile →
Citations per field
00.5×2.6×
Paresh Vyas · 1×
Citations per year

Countries citing papers authored by Soheil Meshinchi

Since Specialization
Citations

This map shows the geographic impact of Soheil Meshinchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soheil Meshinchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soheil Meshinchi more than expected).

Fields of papers citing papers by Soheil Meshinchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soheil Meshinchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soheil Meshinchi. The network helps show where Soheil Meshinchi may publish in the future.

Co-authorship network of co-authors of Soheil Meshinchi

This figure shows the co-authorship network connecting the top 25 collaborators of Soheil Meshinchi. A scholar is included among the top collaborators of Soheil Meshinchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soheil Meshinchi. Soheil Meshinchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 2
3 17
4 26
5 57
6 39
7 11
8 8
9 1
10 20
11 21
12 104
13 96
14 20
15 42
16 52
17
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531breakdown →
313
18 11
19 42
20 32

About Soheil Meshinchi

Soheil Meshinchi is a scholar working on Hematology, Genetics and Cancer Research, having authored 328 papers that have together received 8.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (263 papers), Acute Lymphoblastic Leukemia research (82 papers) and Protein Degradation and Inhibitors (52 papers). The work is most often cited by research in Hematology (5.8k citations), Genetics (1.2k citations) and Public Health, Environmental and Occupational Health (2.7k citations). Soheil Meshinchi has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Todd A. Alonzo, Robert B. Gerbing, Jerald P. Radich, Derek L. Stirewalt, R.J. Arceci, Alan S. Gamis, Susana C. Raimondi, Ching‐Hon Pui, Betsy Hirsch and William L. Carroll. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026